Summit Therapeutics

Summit Therapeutics is a leading healthcare organization dedicated to developing innovative and patient-friendly medications for serious unmet medical needs. With a mission to improve the quality and duration of life and address serious healthcare needs, Summit takes full responsibility for all aspects of drug development, from designing and developing therapies to regulatory submission and successful commercialization. The company's strategy involves identifying and controlling promising product candidates based on exceptional scientific development and administrative expertise.

Summit aims to develop products rapidly and cost-efficiently, while also engaging commercialization and development partners when necessary. With a team of world-class professional scientists and business administrators, Summit strives to be a top market share leader in medicinal therapeutic healthcare. The company fosters continuous expansion of knowledge, ability, capability, and well-being for all stakeholders and highly-valued shareholders.

Founded in 2003 and listed on the Nasdaq Global Market, Summit is headquartered in Menlo Park, California, with additional offices in Oxford, UK. With its dedication to innovation and patient care, Summit Therapeutics is at the forefront of advancing medical treatments